The NLRP3 Inflammasome in Non-Alcoholic Fatty Liver Disease and Steatohepatitis: Therapeutic Targets and Treatment

Non-alcoholic fatty liver disease (NAFLD) is among the most prevalent primary liver diseases worldwide and can develop into various conditions, ranging from simple steatosis, through non-alcoholic steatohepatitis (NASH), to fibrosis, and eventually cirrhosis and hepatocellular carcinoma. Nevertheles...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Lili, Hong, Wei, Lu, Shen, Li, Yanrong, Guan, Yaya, Weng, Xiaogang, Feng, Zhiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957978/
https://www.ncbi.nlm.nih.gov/pubmed/35350750
http://dx.doi.org/10.3389/fphar.2022.780496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957978/
https://www.ncbi.nlm.nih.gov/pubmed/35350750
http://dx.doi.org/10.3389/fphar.2022.780496

Ejemplares similares